Every 10-Q that VALUENCE MERGER CORP I (VMCWF) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow VMCWF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VMCWF filings page.
Valuence Merger Corp. I, a Cayman Islands special purpose acquisition company, reported small operating losses for the three and six months ended June 30, 2026, driven by general and administrative expenses of $243,123 for the first half, partially offset by $177,739 of interest income on funds in its Trust Account, resulting in a net loss of $65,384.
Total assets were dominated by the Trust Account balance of $5.9 million, down sharply from prior levels following multiple shareholder redemptions. After the February 2026 meeting, an additional 1,404,164 Class A shares were redeemed for about $17.6 million, leaving 463,238 Class A shares subject to redemption at $12.77 per share.
The company showed a working capital deficit of $5.1 million, with current liabilities of $5.2 million, including $1.87 million of new 2026 convertible promissory notes and earlier working capital loans. These related-party debts were restructured on June 30, 2026 into three new notes that are non-interest bearing and potentially convertible into warrants. Management disclosed that limited cash of $8,795, the deficit position, and the requirement to complete a Business Combination by up to March 3, 2027 raise substantial doubt about the company’s ability to continue as a going concern.
Valuence Merger Corp. I, a SPAC, filed its quarterly report for the three months ended March 31, 2026, showing minimal operations and net income of $8,303 driven by interest on trust funds. The trust account held about $5.8 million after large redemptions, with only 463,238 Class A shares still subject to redemption.
The company has just $2,521 of cash outside the trust and a working capital deficit of about $5.2 million, funded mainly by related-party loans and convertible notes. Management discloses substantial doubt about its ability to continue as a going concern if no business combination is completed by the extended deadline up to March 3, 2027.
Shareholders have repeatedly extended the merger deadline, and sponsors have deposited roughly $2.3 million of extension contributions into the trust. The stock was delisted from Nasdaq in March 2025 and now trades on the OTC Pink market, while the SPAC continues searching for a target in Asian life sciences or sustainable technology.
Valuence Merger Corp. I filed its quarterly report for the period ended September 30, 2025. The SPAC reported net income of $156,241 for the quarter and $239,933 year-to-date, driven mainly by $187,803 of interest from its Trust Account. Cash was $43,136, and the Trust Account held $22,985,208.
The balance sheet shows a working capital deficit of $4,768,480, total liabilities of $12,942,082, and $8,105,480 in deferred underwriting fees. 1,867,402 Class A shares are subject to redemption at $12.31 per share. As of November 14, 2025, there were 7,369,890 Class A shares and 2 Class B shares outstanding.
The company extended its business combination deadline monthly and may extend up to March 3, 2026 under its approved structure. It disclosed substantial doubt about its ability to continue as a going concern absent a business combination. On March 11, 2025, trading of its securities was suspended on Nasdaq, and trading commenced on the over‑the‑counter market shortly thereafter.